Edaravone Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 13
SKU : PH3561
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What are the key factors driving Edaravone market growth?
The increasing incidence of ALS, FDA approval for ALS treatment, and ongoing clinical trials are key factors driving the Edaravone market growth.
Which segment is expected to hold the largest share in the Edaravone market?
The injection segment is expected to hold the largest share due to its rapid onset of drug effects and ease of administration.
Who are the major players in the Edaravone market?
Sun Pharmaceutical Industries, Unichem Laboratories, and Mitsubishi Tanabe Pharma are some of the major players in the global Edaravone market.
What are the key factors driving the Edaravone market?
ALS cases are steadily increasing, creating a larger demand for Edaravone, the only FDA-approved treatment.
Related Reports
pharmaceuticals

Amyotrophic Lateral Sclerosis (ALS) Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17
Starting from

$4350

pharmaceuticals

Multiple Sclerosis Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
Starting from

$4350

pharmaceuticals

Systemic Sclerosis Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 05
Starting from

$4350

pharmaceuticals

Lichen Sclerosus Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 03
Starting from

$4350

agriculture

Feed Antioxidants Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 19
Starting from

$4350

food-and-beverages

Food Antioxidants Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 29
Starting from

$4350